Unveiling the Complex Reality of CDKL5 Deficiency Disorder
A Rare and Devastating Disorder
CDKL5 Deficiency Disorder (CDD) is a severe and uncommon developmental and epileptic encephalopathy (DEE) that affects a mere 1 in 40,000 to 60,000 live births. The journey with CDD begins in infancy, usually within the first three months of life, and continues into adulthood, presenting a lifelong challenge.
The Battle Against Seizures
From the very start, children with CDD face frequent and relentless seizures that defy conventional treatment. Despite the availability of anti-seizure medications, these seizures persist, requiring multiple drugs that often provide only temporary relief. For many, the battle against seizures is an ongoing and exhausting one.
The types of seizures experienced by CDD patients vary throughout their lives. Initially, they may suffer from epileptic spasms (brief, clustered jerks) or tonic seizures (sudden muscle stiffening). Over time, new focal and generalized seizures emerge, while others may subside, creating a complex and ever-changing landscape of neurological challenges.
Beyond Seizures: A Multifaceted Disorder
CDD is not just about seizures. It brings a host of neurodevelopmental delays that impact various aspects of life. Cognition, motor skills, speech, sleep, and even gastrointestinal and visual functions are affected. For many patients and their families, simple milestones like walking or speaking their first words remain elusive.
Gastrointestinal issues are prevalent, often leading to the need for a gastronomy tube. Sleep disturbances, musculoskeletal complications such as scoliosis, and visual impairments further complicate daily life and communication, adding another layer of difficulty to an already challenging reality.
The Impact on Families: A Heavy Burden
Parents of children with CDD become full-time advocates, caregivers, and therapists. The emotional toll is immense as they dedicate their lives to providing round-the-clock care, often sacrificing career opportunities and social connections. The lack of a specific treatment for CDD leaves many parents feeling isolated and disappointed.
Statistics suggest that nearly half of those living with CDD are on three or more anti-seizure medications, yet most still struggle to control their seizures. The rarity and complexity of CDD often lead to delayed diagnoses, further exacerbating the emotional and practical burdens on families and hindering their access to specialized care and support networks.
Looking Ahead: Hope and Resilience
At the American Epilepsy Society Congress, we presented promising phase 3 data in CDD, offering a glimmer of hope. The resilience and strength of families living with CDD inspire us daily. Their unwavering spirit motivates us to push the boundaries of scientific discovery and seek innovative solutions to address the significant unmet needs in CDD.
Together, let's continue to raise awareness, advocate for better treatments, and support those affected by CDD. By joining forces, we can ensure that no one faces this journey alone and create a brighter, more hopeful future for CDD families and patients.
